bluuebunny/crossref_metadata_2025_split huggingface dataset:
Spatiotemporal changes and driving factors of reference evapotranspiration and crop evapotranspiration for cotton production in China from 1960 to 2019
Authors: Su Yuexia , Wang Jian , Li Junhong , Wang Lizhi , Wang Kunfeng , Li Ao , Gao Lei , Wang Zhanbiao 
Published: September 2023

Introduction: Understanding and tracking changes in crop water requirements is crucial for effective irrigation, water planning, and future decisions. Determining the reference evapotranspiration (ETO) and crop evapotranspiration (ETC) of China cotton is essential for water resource management.Methods: This study analyzed the spatiotemporal changes in ETO and ETC at 248 standard stations in cotton production regions of China from 1960 to 2019, and the ETO and ETC of each station were quantified by using the CropWat 8.0 and non-parametric Mann-Kendall test. The impacts of climate change on ETO and ETC were evaluated by analyzing the contribution rate and sensitivity coefficient of climate change.Discussion: The results revealed distinct distributions of ETO and ETC across various growth stages and spatial scales in the cotton production regions of China. In the Huanghe Valley, the rate of decline for ETO decreased from 787.23 mm to 769.84 mm, while in the Yangtze Valley cotton region, it decreased from 749.19 mm to 735.01 mm. Similarly, in the Northwest inland cotton regions, the rate of decline for ETO reduced from 991.19 mm to 982.70 mm. As for ETC, the rate of decline decreased from 677.62 mm to 654.33 mm in the Huanghe Valley, from 653.02 mm to 625.50 mm in the Yangtze Valley, and from 916.25 mm to 886.74 mm in the Northwest inland cotton regions. ETO was highly sensitive to maximum air temperature (Tmax), followed by relative humidity (RH), sunshine duration (SD), wind speed at 2 m height (WS), and minimum air temperature (Tmin). WS was the most influential climate variable associated with ETO change, followed by Tmax, SD, RH, and Tmin. Significant declines in WS and SD were indicated in the decrease in ETO in the Huanghe Valley and Yangtze Valley cotton regions. WS showed a significant decrease in ETO in the northwestern inland cotton region. However, decreased RH and increased temperature commonly reversed the trend of ETO from 2000 to 2019, and the northwestern inland cotton region had the most significant upward trend. Amidst high temperatures and drought stress, the irrigation needs of cotton were rising, posing a significant threat to both cotton production and water resources.
Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load
Authors: Grant-McAuley Wendy , Morgenlander William , Hudelson Sarah E. , Thakar Manjusha , Piwowar-Manning Estelle , Clarke William , Breaud Autumn , Blankson Joel , Wilson Ethan , Ayles Helen , Bock Peter , Moore Ayana , Kosloff Barry , Shanaube Kwame , Meehan Sue-Ann , van Deventer Anneen , Fidler Sarah , Hayes Richard , Ruczinski Ingo , Kammers Kai , Laeyendecker Oliver , Larman H. Benjamin , Eshleman Susan H. 
Published: September 2023

BackgroundHigh HIV viral load (VL) is associated with increased transmission risk and faster disease progression. HIV controllers achieve viral suppression without antiretroviral (ARV) treatment. We evaluated viremic control in a community-randomized trial with &gt;48,000 participants.MethodsA massively multiplexed antibody profiling system, VirScan, was used to quantify pre- and post-infection antibody reactivity to HIV peptides in 664 samples from 429 participants (13 controllers, 135 viremic non-controllers, 64 other non-controllers, 217 uninfected persons). Controllers had VLs &lt;2,000 copies/mL with no ARV drugs detected at the first HIV-positive visit and one year later. Viremic non-controllers had VLs 2,000 copies/mL with no ARV drugs detected at the first HIV-positive visit. Other non-controllers had either ARV drugs detected at the first HIV-positive visit (n=47) or VLs &lt;2,000 copies/mL with no ARV drugs detected at only one HIV-positive visit (n=17).ResultsWe identified pre-infection HIV antibody reactivities that correlated with post-infection VL. Pre-infection reactivity to an epitope in the HR2 domain of gp41 was associated with controller status and lower VL. Pre-infection reactivity to an epitope in the C2 domain of gp120 was associated with non-controller status and higher VL. Different patterns of antibody reactivity were observed over time for these two epitopes.ConclusionThese studies suggest that pre-infection HIV antibodies are associated with controller status and modulation of HIV VL. These findings may inform research on antibody-based interventions for HIV treatment.
Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer
Authors: Mistretta Brandon , Rankothgedera Sakuni , Castillo Micah , Rao Mitchell , Holloway Kimberly , Bhardwaj Anjana , El Noafal Maha , Albarracin Constance , El-Zein Randa , Rezaei Hengameh , Su Xiaoping , Akbani Rehan , Shao Xiaoshan M. , Czerniecki Brian J. , Karchin Rachel , Bedrosian Isabelle , Gunaratne Preethi H. 
Published: September 2023

IntroductionWe present here a strategy to identify immunogenic neoantigen candidates from unique amino acid sequences at the junctions of fusion proteins which can serve as targets in the development of tumor vaccines for the treatment of breastcancer.MethodWe mined the sequence reads of breast tumor tissue that are usually discarded as discordant paired-end reads and discovered cancer specific fusion transcripts using tissue from cancer free controls as reference. Binding affinity predictions of novel peptide sequences crossing the fusion junction were analyzed by the MHC Class I binding predictor, MHCnuggets. CD8+ T cell responses against the 15 peptides were assessed through in vitro Enzyme Linked Immunospot (ELISpot).ResultsWe uncovered 20 novel fusion transcripts from 75 breast tumors of 3 subtypes: TNBC, HER2+, and HR+. Of these, the NSFP1-LRRC37A2 fusion transcript was selected for further study. The 3833 bp chimeric RNA predicted by the consensus fusion junction sequence is consistent with a read-through transcription of the 5’-gene NSFP1-Pseudo gene NSFP1 (NSFtruncation at exon 12/13) followed by trans-splicing to connect withLRRC37A2 located immediately 3’ through exon 1/2. A total of 15 different 8-mer neoantigen peptides discovered from the NSFP1 and LRRC37A2 truncations were predicted to bind to a total of 35 unique MHC class I alleles with a binding affinity of IC50&lt;500nM.); 1 of which elicited a robust immune response.ConclusionOur data provides a framework to identify immunogenic neoantigen candidates from fusion transcripts and suggests a potential vaccine strategy to target the immunogenic neopeptides in patients with tumors carrying the NSFP1-LRRC37A2 fusion.
Case report: Preliminary study on the diagnosis and treatment of respiratory distress in patients with giant nodular goiter complicated with severe COVID-19
Authors: Wang Fang , Yu Xing , Ren Zhangxia , Wang Yong 
Published: September 2023

BackgroundTo investigate the practicality of emergency surgical and conservative medical treatments in patients with giant nodular goiter complicated by severe coronavirus disease 2019 (COVID-19)-related respiratory distress, evaluate the prognosis based on the two interventions, and explore the diagnosis and treatment plan of COVID-19-related respiratory distress in patients with giant nodular goiter.MethodsFour cases were retrospectively collected. Among them, two cases underwent emergency surgery, one case was treated with conservative treatment, whereas the fourth case underwent emergency surgery after failure of conservative therapy.ResultsDyspnea was significantly improved postoperatively, and the endotracheal tube was successfully removed 10.5 h after the operation, but inflammatory markers were greatly enhanced as compared to the preoperative values, patients with different degrees of fever, cough, and other discomforts postoperatively. Case 1 showed complete remission of all symptoms after 3 weeks, while case 2 displayed fever, cough, drowsiness, and other symptoms after the discharge and was eventually readmitted. In case 3, the conservative COVID-19 treatment marginally improved the pulmonary infection, fever, and other symptoms, but cough and other discomforts were persistent, along with delirium in later stages. Moreover, case 4 reported extubation failure after undergoing treatment with the standard new coronary pneumonia regimen in the tracheal intubation state; however, the patient was successfully weaned and extubated 9 days after emergency surgery to relieve the obstruction.ConclusionOur preliminary exploration suggested that patients with giant nodular goiter and respiratory tract obstruction post-acute COVID-19 infection can undergo early surgery after surgical tolerance evaluation for a better prognosis.
Quality of life 1 year after hospital discharge in unvaccinated pregnant women with COVID-19 respiratory symptoms: a prospective observational study (ODISSEA-PINK study)
Authors: Vetrugno Luigi , Sala Alessia , Deana Cristian , Meroi Francesco , Grandesso Maria , Maggiore Salvatore Maurizio , Isola Miriam , De Martino Maria , Restaino Stefano , Vizzielli Giuseppe , Bove Tiziana , Driul Lorenza 
Published: September 2023

IntroductionLittle is known about Quality of Life within the first court of unvaccinated COVID-19 pregnant women exposed to the pandemic stressor. Primary aim of this study was to evaluate 1 year after hospital discharge HRQoL in a cohort of COVID-19 unvaccinated pregnant patients with COVID-19.Methodsin this prospective observational study, all COVID-19 positive pregnant women at any gestational age, admitted to the Obstetric Department at the University Hospital of Udine, Italy, from 1 March 2020 to 1 March 2021, requiring or not oxygen supplementation due to SARS-CoV2 pneumonia were evaluated. Patients with a history of neurological or psychiatric disease, those with a previous abortion, and those who refused to provide written informed consent were excluded from the study. We investigated pregnant positive COVID-19 women Health-related quality of life (HRQoL) with the Short-Form Health Survey-36 (SF-36) and Post-traumatic Stress-Disorder (PTSD) with the Impact of Event Scale-Revised (IES-R).Results62 pregnant women respected the inclusion criteria of the study, and data from 33 patients were analyzed. The mean age was 32 ± 6 years, with a median gestational age of 38 weeks [IQR 34–40]. 15.2% of patients required oxygen therapy through noninvasive respiratory support (with high flow nasal cannula) for a median of 9 days [IQR 6–12]. The median Physical Component Summary (PCS) and Mental Component Summary (MCS) scores were 50.2 [IQR 46.7–53.7] and 56.0 [IQR 46.8–60.6] respectively. Ten patients out of 33 (30%) tested positive for PTSD. Maternal age, gestational age, and history of cardiac-pulmonary-kidney disease significantly affected HRQoL at multivariable analysis.DiscussionIn COVID-19 pregnant unvaccinated women some physical impairments reducing HRQoL are still present 1 year after hospital discharge. Previous medical history such as history of cardiac-pulmonary-kidney disease significantly affected HRQoL. Long and repeated follow-up should be pursued in this category of patients.Clinical trial registration:ClinicalTrials.gov, Identifier NCT04860687.
Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
Authors: Dong Yaping , Shi Sufang , Liu Lijun , Zhou Xujie , Lv Jicheng , Zhang Hong 
Published: September 2023

BackgroudRecent trials suggest sodium-glucose cotransporter 2 inhibitors (SGLT2i) significantly reduced proteinuria in patients with IgA nephropathy (IgAN). While little was known its efficacy in clinical practice especially in those already received full dose reninangiotensin-aldosterone system (RAAS) inhibitors.MethodsA cohort of 93 Chinese patients with biopsy-proven IgAN and persistent proteinuria underwent full supportive therapy, including optimal blood pressure control and full dose angiotensin-converting enzyme–inhibitor or angiotensin receptor blocker therapy. Proteinuria reduction at three and six months after initiating SGLT2i therapy was analyzed.ResultsA total of 93 patients were enrolled in this study and 62 of them completed the six-month follow-up. After SGLT2i administration, a significant reduction in proteinuria was observed, with a decrease of 22.9% (p &lt; 0.001) at three months and 27.1% (p &lt; 0.001) at six months. During the six-month follow-up period, a decline of 3.0 mL/min/1.73m2 in estimated glomerular filtration rate (eGFR) (p = 0.012) and an increase of 0.8 g/L in albumin (p = 0.017) were observed. The anti-hypertensive effect of SGLT2i was not significant (p &gt; 0.05). Notably, a consistent antiproteinuric effect of SGLT2i was observed across various settings, including different age groups, baseline levels of proteinuria/eGFR, use of immunosuppressive agents, and the presence of comorbid diabetes and hypertension (all p values &gt;0.05).ConclusionThe proteinuria was significantly reduced after SGLT2i administration in IgAN patients with full dose angiotensin-converting enzyme–inhibitor or angiotensin receptor blocker therapy. Importantly, the antiproteinuric effect of SGLT2i was observed independently of immunosuppressive agent therapy, age, baseline eGFR and proteinuria levels, as well as the history of hypertension and diabetes.
Associations between non-motor symptoms and patient characteristics in Parkinson’s disease: a multicenter cross-sectional study
Authors: Morimoto Remi , Iijima Mutsumi , Okuma Yasuyuki , Suzuki Keisuke , Yoshii Fumihito , Nogawa Shigeru , Osada Takashi , Kitagawa Kazuo 
Published: September 2023

ObjectiveParkinson’s disease (PD) is characterized by various non-motor symptoms (NMS), such as constipation, olfactory disturbance, sleep disturbance, mental disorders, and motor symptoms. This study aimed to investigate factors associated with NMS in patients with PD.MethodsSymptoms of PD were evaluated using the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), Parts I–IV. NMS was assessed using the MDS-UPDRS Part I (self-assessment of NMS) and rapid eye movement sleep behavior disorder (RBD) questionnaires. Patients were categorized by age into &lt;70 years and ≥ 70 years (older adults) groups, according to disease duration into early-stage and advanced-stage groups with a cut-off value of 5 years for motor symptoms, and by sex into male and female groups.ResultsA total of 431 patients with PD (202 males and 229 females) with a mean age of 67.7 years, a mean disease duration of 6.4 years, and a mean Part I total score of 9.9 participated in this study. The Part I total score was significantly positively correlated (p &lt; 0.01) with disease duration and Part II, III, and IV scores. For Part I sub-item scores, the older group had significantly higher scores for cognitive impairment, hallucinations, sleep problems, urinary problems, and constipation than the &lt;70 years group, whereas the advanced-stage group had significantly higher scores for hallucinations, sleep problems, daytime sleepiness, pain, urinary problems, and constipation (p &lt; 0.05) than the early-stage group. Anxiety was higher in female patients than in male patients, whereas daytime sleepiness, urinary problems, and RBD were higher in male patients than in female patients (p &lt; 0.05). Factors affecting Part I included disease duration, Part II total scores, Part IV total scores, and RBD.ConclusionAccording to the self-questionnaire assessment, NMS was highly severe in older adult patients, those with longer illness duration, subjective and objective motor function impairments, and RBD. Sex-based differences were also observed.
End of life care of hospitalized patients with Parkinson disease: a retrospective analysis and brief review
Authors: Bhansali Sakhi , Assaedi Ekhlas , Yu Jeryl Ritzi T. , Mandava Nymisha , Sonneborn Claire , Hogue Olivia , Walter Benjamin L. , Samala Renato V. , Margolius Adam 
Published: September 2023

BackgroundTowards the end of life (EOL), persons with parkinsonism (PwP) have complex needs and can present with unique palliative care (PC) challenges. There are no widely accepted guidelines to aid neurologists, hospitalists, or PC clinicians in managing the symptoms of PwP at EOL. We examined a population of PwP at EOL, aiming to describe trends of in-hospital management and utilization of PC services.MethodsAll PwP admitted to two hospitals during 2018 (N = 727) were examined retrospectively, assessing those who died in hospital or were discharged with hospice (EOL group, N = 35) and comparing them to the main cohort. Their demographics, clinical data, engagement of multidisciplinary and palliative services, code status changes, invasive care, frequency of admissions, and medication administration were assessed.ResultsAmong the EOL group, 8 expired in hospital, and 27 were discharged to hospice. Forty-six percent of EOL patients received a PC consultation during their admission. The median interval from admission to death was 37 days. Seventy-seven percent had a full code status on admission. Compared to hospice patients, those who expired in hospital had higher rates of invasive procedures and intensive care unit transfers (41% vs. 75%, in both variables), and lower rates of PC involvement (52% vs. 25%). The transition of code status change for the EOL group from Full code to Do Not Resuscitate (DNR) occurred at a median 4–5 days from admission. For patients that passed in the hospital, the median days from transition of code status to death was 0(IQR 0–1). Levodopa dose deviations were frequent in both EOL and non-EOL group, but contraindicated medications were infrequently administered (11% in EOL group vs. 9% in non-EOL group).ConclusionOur data suggest a low utilization of PC services and delayed discussions of goals of care. More work is needed to raise awareness of inpatient teams managing PwP regarding the unique but common challenges facing PwP with advanced disease. A brief narrative review summarizing the suggested management of symptoms common to hospitalized PwP near EOL is provided.
Modulation of ipsilateral motor evoked potentials during bimanual coordination tasks
Authors: Altermatt Miriam , Jordan Harry , Ho Kelly , Byblow Winston D. 
Published: September 2023

IntroductionIpsilateral motor evoked potentials (iMEPs) are difficult to obtain in distal upper limb muscles of healthy participants but give a direct insight into the role of ipsilateral motor control.MethodsWe tested a new high-intensity double pulse transcranial magnetic stimulation (TMS) protocol to elicit iMEPs in wrist extensor and flexor muscles during four different bimanual movements (cooperative—asymmetric, cooperative—symmetric, non-cooperative—asymmetric and non-cooperative—symmetric) in 16 participants.ResultsNine participants showed an iMEP in the wrist extensor in at least 20% of the trials in each of the conditions and were classified as iMEP+ participants. iMEP persistence was greater for cooperative (50.5 ± 28.8%) compared to non-cooperative (31.6 ± 22.1%) tasks but did not differ between asymmetric and symmetric tasks. Area and amplitude of iMEPs were also increased during cooperative (area = 5.41 ± 3.4 mV × ms; amplitude = 1.60 ± 1.09 mV) compared to non-cooperative (area = 3.89 ± 2.0 mV × ms; amplitude = 1.12 ± 0.56 mV) tasks and unaffected by task-symmetry.DiscussionThe upregulation of iMEPs during common-goal cooperative tasks shows a functional relevance of ipsilateral motor control in bimanual movements. The paired-pulse TMS protocol is a reliable method to elicit iMEPs in healthy participants and can give new information about neural control of upper limb movements. With this work we contribute to the research field in two main aspects. First, we describe a reliable method to elicit ipsilateral motor evoked potentials in healthy participants which will be useful in further advancing research in the area of upper limb movements. Second, we add new insight into the motor control of bimanual movements. We were able to show an upregulation of bilateral control represented by increased ipsilateral motor evoked potentials in cooperative, object-oriented movements compared to separate bimanual tasks. This result might also have an impact on neurorehabilitation after stroke.
The effect of breakfast on childhood obesity: a systematic review and meta-analysis
Authors: Wang Kun , Niu Yifan , Lu Zhenzhen , Duo Boyang , Effah Clement Yaw , Guan Lina 
Published: September 2023

ObjectivePrevious cohort trials have shown that skipping breakfast increases the risk of obesity or overweight in children. However, this finding remains controversial. Through a meta-analysis, this study systematically evaluated the effect of skipping breakfast on the prevalence of obesity or overweight in children.MethodsWe performed a literature search for studies published until March 19, 2023. using the Cochrane, PubMed, and Embase databases. Based on the inclusion and exclusion criteria, observational studies on the relationship between skipping breakfast and overweight/obesity in children and adolescents were analyzed. Three investigators independently screened the relevant literature, extracted the data, and assessed the risk of bias. The quality of the included studies was assessed using the Newcastle-Ottawa Scale (NOS). A random-effects model was used. The odds ratio (OR) with its 95% confidence interval (CI) was used to indicate the effect size.ResultsA total of 40 retrospective studies with 323,244 children ranging in age from 2 to 20 years were included in this study. The results of this meta-analysis showed that children and adolescents who skipped breakfast had a significantly higher prevalence of obesity or overweight than those who ate breakfast (OR, 1.59; 95% CI, 1.33–1.90; P &lt; 0.001). Skipping breakfast was positively associated with overweight in children and adolescents (OR, 1.37; 95% CI, 1.23–1.54; P &lt; 0.001). Similarly, skipping breakfast was positively associated with obesity in children and adolescents (OR, 1.51; 95% CI, 1.30–1.76; P &lt; 0.001). The effect was also different by sex, with girls being the most affected (OR, 1.47; 95% CI, 1.23–1.76; P &lt; 0.001). There was also a correlation between skipping breakfast and abdominal obesity in children (OR, 0.65; 95% CI, 0.55–0.77; P &lt; 0.001).ConclusionThis meta-analysis suggested that skipping breakfast is associated with an increased risk of overweight/obesity in children and adolescents. The findings provide support for a possible protective role of breakfast against excessive weight gain in children and adolescents. However, more rigorous study designs with validated and standardized measures of relevant variables are needed.